Table 2.
Comorbidities Stratified by History of VTE in GOLD Stage ll-IV Participants
| VTE− | (n=3479) | VTE+ | (n=210) | P | |
|---|---|---|---|---|---|
| n | % | n | % | ||
| Bladder Cancer | 30 | 0.9 | 5 | 2.4 | 0.028 |
| Breast Cancer | 75 | 2.2 | 7 | 3.3 | 0.261 |
| Colon Cancer | 30 | 0.9 | 2 | 1.0 | 0.891 |
| Prostate Cancer | 103 | 3.0 | 10 | 4.8 | 0.142 |
| Angina | 177 | 5.1 | 23 | 11.0 | <0.0001 |
| Congestive Heart Failure | 170 | 4.9 | 28 | 13.3 | <0.0001 |
| Diabetes | 445 | 12.8 | 37 | 17.6 | <0.0001 |
| High Blood Pressure | 1747 | 50.2 | 121 | 57.6 | 0.044 |
| Coronary Artery Disease | 301 | 8.7 | 40 | 19.0 | 0.038 |
| Hypercholesterolemia | 1419 | 40.8 | 109 | 51.9 | 0.001 |
| Myocardial Infarction | 263 | 7.6 | 34 | 16.2 | <0.0001 |
| Peripheral Vascular Disease | 94 | 2.7 | 32 | 15.2 | <0.0001 |
| Stroke | 115 | 3.3 | 17 | 8.1 | <0.0001 |
| Transient Ischemic Attack | 97 | 2.8 | 15 | 7.1 | <0.0001 |
| Macular Degeneration | 95 | 2.7 | 11 | 5.2 | 0.035 |
| Pneumothorax | 164 | 4.7 | 19 | 9.0 | 0.005 |
| Gastroesophageal Reflux | 1032 | 29.7 | 84 | 40.0 | 0.002 |
| PepticUlcer Disease | 342 | 9.8 | 30 | 14.3 | 0.037 |
| Compression Fractures | 211 | 6.1 | 19 | 9.0 | 0.083 |
| Hip Fracture | 83 | 2.4 | 7 | 3.3 | 0.387 |
| Osteoarthritis | 701 | 20.1 | 148 | 70.5 | 0.001 |
| Osteoporosis | 454 | 13.0 | 42 | 20.0 | 0.004 |
| Rheumatoid Arthritis | 301 | 8.7 | 24 | 11.4 | 0.169 |